$MIND
MIND TECHNOLOGY, INC Stock $mind

$mind Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923017412 Filed on June 14, 2023

Income Statement

Concept	2023 Q2	2022 Q2
Revenue	$12.59M	$9.087M
YoY Change	38.51%	116.67%
Cost Of Revenue	$7.169M	$5.798M
YoY Change	23.65%	58.81%
Gross Profit	$5.417M	$3.289M
YoY Change	64.7%	505.71%
Gross Profit Margin	43.04%	36.19%
Selling, General & Admin	$3.874M	$4.272M
YoY Change	-9.32%	11.92%
% of Gross Profit	71.52%	129.89%
Research & Development	$773.0K	$1.014M
YoY Change	-23.77%	18.87%
% of Gross Profit	14.27%	30.83%
Depreciation & Amortization	$481.0K	$479.0K
YoY Change	0.42%	-28.08%
% of Gross Profit	8.88%	14.56%
Operating Expenses	$5.128M	$5.765M
YoY Change	-11.05%	8.04%
Operating Profit	$289.0K	-$2.476M
YoY Change	-111.67%	-48.34%
Interest Expense	-$204.0K	-$4.000K
YoY Change	5000.0%
% of Operating Profit	-70.59%
Other Income/Expense, Net	-$111.0K	-$118.0K
YoY Change	-5.93%	-112.46%
Pretax Income	$178.0K	-$2.600M
YoY Change	-106.85%	-31.58%
Income Tax	$418.0K	$211.0K
% Of Pretax Income	234.83%
Net Earnings	-$240.0K	-$2.419M
YoY Change	-90.08%	-39.28%
Net Earnings / Revenue	-1.91%	-26.62%
Basic Earnings Per Share	-$0.09	-$0.24
Diluted Earnings Per Share	-$0.09	-$0.24
COMMON SHARES
Basic Shares Outstanding	13.79M	13.78M
Diluted Shares Outstanding	13.79M	13.78M

Balance Sheet

Concept	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$815.0K	$817.0K
YoY Change	-0.24%	-59.17%
Cash & Equivalents	$815.0K	$817.0K
Short-Term Investments
Other Short-Term Assets	$1.088M	$1.561M
YoY Change	-30.3%	-72.33%
Inventory	$14.34M	$14.24M
Prepaid Expenses
Receivables	$7.390M	$9.397M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$23.63M	$26.02M
YoY Change	-9.17%	10.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.787M	$4.062M
YoY Change	-6.77%	-11.43%
Goodwill		$0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$428.0K
YoY Change
Total Long-Term Assets	$10.21M	$11.76M
YoY Change	-13.18%	-2.46%
TOTAL ASSETS
Total Short-Term Assets	$23.63M	$26.02M
Total Long-Term Assets	$10.21M	$11.76M
Total Assets	$33.85M	$37.78M
YoY Change	-10.42%	6.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.206M	$2.084M
YoY Change	-42.13%	-2.71%
Accrued Expenses	$3.391M	$5.699M
YoY Change	-40.5%	87.59%
Deferred Revenue	$486.0K	$559.0K
YoY Change	-13.06%	-0.71%
Short-Term Debt	$3.139M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.945M	$9.617M
YoY Change	3.41%	16.12%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.009M	$944.0K
YoY Change	6.89%	99.58%
Total Long-Term Liabilities	$1.009M	$944.0K
YoY Change	6.89%	99.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.945M	$9.617M
Total Long-Term Liabilities	$1.009M	$944.0K
Total Liabilities	$10.98M	$10.65M
YoY Change	3.1%	18.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.9M	-$121.2M
YoY Change	5.49%	16.07%
Common Stock	$129.8M	$129.3M
YoY Change	0.36%	0.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$16.86M	$16.86M
YoY Change	0.0%	0.01%
Treasury Stock Shares		$1.933M
Shareholders Equity	$22.86M	$27.13M
YoY Change
Total Liabilities & Shareholders Equity	$33.85M	$37.78M
YoY Change	-10.42%	6.37%

Cashflow Statement

Concept	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$240.0K	-$2.419M
YoY Change	-90.08%	-39.28%
Depreciation, Depletion And Amortization	$481.0K	$479.0K
YoY Change	0.42%	-28.08%
Cash From Operating Activities	-$2.987M	-$3.522M
YoY Change	-15.19%	25.47%
INVESTING ACTIVITIES
Capital Expenditures	$57.00K	$107.0K
YoY Change	-46.73%	1237.5%
Acquisitions
YoY Change
Other Investing Activities	$138.0K	$283.0K
YoY Change	-51.24%	51.34%
Cash From Investing Activities	$81.00K	$176.0K
YoY Change	-53.98%	-1.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.000K
YoY Change		-102.5%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.945M	-$948.0K
YoY Change	-410.65%	2772.73%
NET CHANGE
Cash From Operating Activities	-$2.987M	-$3.522M
Cash From Investing Activities	$81.00K	$176.0K
Cash From Financing Activities	$2.945M	-$948.0K
Net Change In Cash	$37.00K	-$4.297M
YoY Change	-100.86%	64.64%
FREE CASH FLOW
Cash From Operating Activities	-$2.987M	-$3.522M
Capital Expenditures	$57.00K	$107.0K
Free Cash Flow	-$3.044M	-$3.629M
YoY Change	-16.12%	28.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	504000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	504000	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1683000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1683000
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1683000
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1683000
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15721000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15721000
CY2023Q2	mind	Treasury Stock Common And Preferred Shares TreasuryStockCommonAndPreferredShares	1933000
CY2023Q1	mind	Treasury Stock Common And Preferred Shares TreasuryStockCommonAndPreferredShares	1933000
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y11M8D
CY2023Q2	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13800000
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-04-30
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	001-13490
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	76-0210849
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	2002 Timberloch Place
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	The Woodlands
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77380
CY2023Q2	dei	City Area Code CityAreaCode	281
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	353-4475
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13788738
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	815000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	778000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7390000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3993000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	14339000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	15318000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1088000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2144000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	23632000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	22233000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3787000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3945000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1762000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1749000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4664000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4931000	usd
CY2023Q2	us-gaap	Assets Assets	33845000	usd
CY2023Q1	us-gaap	Assets Assets	32858000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1206000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4101000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	486000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	164000	usd
CY2023Q2	mind	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	2638000	usd
CY2023Q1	mind	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	2247000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1723000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1516000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	753000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	903000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3139000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9945000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8931000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1009000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	846000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	10983000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	9806000	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	37779000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	37779000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	157000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	157000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	129630000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	129580000	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	16863000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	16863000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127875000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127635000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	34000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	34000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	22862000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	23052000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33845000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32858000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12586000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9087000	usd
CY2023Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	7169000	usd
CY2022Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	5798000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	5417000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	3289000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3874000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4272000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	773000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1014000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	481000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	479000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5128000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	5765000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	289000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2476000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-111000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-118000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-111000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-118000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	178000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2594000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	418000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	211000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-240000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2805000	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	386000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-240000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2419000	usd
CY2023Q2	mind	Preferred Stock Dividends Declared PreferredStockDividendsDeclared	-0	usd
CY2022Q2	mind	Preferred Stock Dividends Declared PreferredStockDividendsDeclared	947000	usd
CY2023Q2	mind	Preferred Stock Dividends Undeclared PreferredStockDividendsUndeclared	947000	usd
CY2022Q2	mind	Preferred Stock Dividends Undeclared PreferredStockDividendsUndeclared	-0	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1187000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3366000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.27
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13789000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13775000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13789000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13775000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-240000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2419000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	3000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-240000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2422000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-240000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2419000	usd
CY2023Q2	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	481000	usd
CY2022Q2	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	479000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	50000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	236000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	23000	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3462000	usd
CY2022Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	871000	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-11000	usd
CY2022Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	26000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-979000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	260000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1308000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-286000	usd
CY2023Q2	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	206000	usd
CY2022Q2	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-66000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2788000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-622000	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	606000	usd
CY2022Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-115000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2987000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3522000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	57000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	138000	usd
CY2022Q2	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	283000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	81000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	176000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000	usd
CY2023Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2945000	usd
CY2022Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2023Q2	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	-0	usd
CY2022Q2	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	947000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2945000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-948000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2000	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4297000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	778000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5114000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	815000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	817000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	204000	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	189000	usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	277000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	23052000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-240000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	22862000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	30263000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2419000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	1	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	947000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	236000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	27129000	usd
CY2023Q2	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em> Organization and Liquidity</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 25pt;">MIND Technology, Inc., a Delaware corporation (the “Company”), formerly Mitcham Industries, Inc., a Texas corporation, was incorporated in <em style="font: inherit;">1987.</em> Effective <em style="font: inherit;"> August 3, 2020 </em>the Company effectuated a reincorporation to the state of Delaware. Concurrent with the reincorporation the name of the Company was changed to MIND Technology, Inc. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 25pt;">The Company, through its wholly owned subsidiaries, Seamap Pte Ltd, MIND Maritime Acoustics, LLC, Seamap (Malaysia) Sdn Bhd and Seamap (UK) Ltd (collectively “Seamap”), and Klein Marine Systems, Inc. (“Klein”), designs, manufactures and sells a broad range of proprietary products for the seismic, hydrographic and offshore industries with product sales and support facilities based in Singapore, Malaysia, the United Kingdom and the states of New Hampshire and Texas. Prior to <em style="font: inherit;"> July 31, 2020, </em>the Company, through its wholly owned Canadian subsidiary, Mitcham Canada, ULC (“MCL”), its wholly owned Hungarian subsidiary, Mitcham Europe Ltd. (“MEL”), and its branch operations in Colombia, provided full-service equipment leasing, sales and service to the seismic industry worldwide (the “Leasing Business”). Effective <em style="font: inherit;"> July 31, 2020, </em>the Leasing Business has been classified as held for sale and the financial results reported as discontinued operations (see Note <em style="font: inherit;">3</em> – “Assets Held for Sale and Discontinued Operations” for additional details). All intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 25pt;">These condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. The Company has a history of generating losses and negative cash from operating activities and <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> have access to sources of capital that were available in prior periods. In addition, emerging supply chain disruptions and recent volatility in oil prices have created significant uncertainty in the global economy which could have a material adverse effect on the Company’s business, financial position, results of operations and liquidity. Accordingly, substantial doubt has arisen regarding the Company’s ability to continue as a going concern. These consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that <em style="font: inherit;"> may </em>result should the Company <em style="font: inherit;">not</em> be able to continue as a going concern.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 25pt;">Management has identified the following mitigating factors regarding adequate liquidity and capital resources to meet its obligations:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The Company has <em style="font: inherit;">no</em> obligations or agreements containing “maintenance type” financial covenants.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The Company had working capital of approximately $13.7 million as of <em style="font: inherit;"> April 30, 2023, </em>including cash of approximately $815,000.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Should revenues be less than projected, the Company believes it is able, and has plans in place, to reduce costs proportionately in order to maintain positive cash flow.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The majority of the Company’s costs are variable in nature, such as raw materials and personnel related costs. The Company has recently eliminated <em style="font: inherit;">two</em> executive level positions and other administrative positions, and additional reductions in operations, sales, and general and administrative headcount could be made, if deemed necessary by management.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The Company had a backlog of orders of approximately $22.6 million as of <em style="font: inherit;"> April 30, 2023. </em>Production for certain of these orders was in process and included in inventory as of <em style="font: inherit;"> April 30, 2023, </em>thereby reducing the liquidity needed to complete the orders.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt;">There were no dividends declared or paid on the Company’s Preferred stock for the <em style="font: inherit;">first</em> quarter of fiscal <em style="font: inherit;">2024.The</em> Company declared and paid the quarterly dividend on its Preferred Stock for the <em class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="font: inherit;">first</em> quarter of fiscal <em style="font: inherit;">2023,</em> but deferred all dividend payments for the subsequent quarters of fiscal <em style="font: inherit;">2023.</em> The Company also has the option to defer future quarterly dividend payments if deemed necessary. The dividends are a cumulative dividend that accrue for payment in the future. During a deferral period, the Company is prohibited from paying dividends or distributions on its common stock or redeeming any of those shares. Further, if the Company does <em style="font: inherit;">not</em> pay dividends on its Series A Preferred Stock for <em style="font: inherit;">six</em> or more quarters, the holders of Series A Preferred Stock will have the right to appoint <em style="font: inherit;">two</em> directors to the Company's board.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;">In recent years, the Company has raised capital through the sale of Common Stock and Preferred Stock pursuant to the ATM Offering Program (as defined herein) and underwritten offerings on Form S-<em style="font: inherit;">1.</em> Currently, the Company is <em style="font: inherit;">not</em> eligible to issue securities pursuant to Form S-<em style="font: inherit;">3</em> and accordingly cannot sell securities pursuant to the ATM Offering Program. However, the Company <em style="font: inherit;"> may </em>sell securities pursuant to Form S-<em style="font: inherit;">1</em> or in private transactions. Management expects to be able to raise further capital through these available means should the need arise.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;">•</td><td style="width: auto;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;">Based on publicized transactions and preliminary discussions with potential funding sources, management believes that other sources of debt and equity financing are available. Such sources could include private or public issues of equity or debt securities, or a combination of such securities. Other sources could include secured debt financing, sale-leaseback transactions on owned real estate or investment from strategic industry participants. There can be <em style="font: inherit;">no</em> assurance that any of these sources will be available to the Company, available in adequate amounts, or available under acceptable terms should the need arise.</p> </td></tr> </tbody></table> <p style="margin: 0pt; font-family: "Times New Roman"; font-size: 10pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 25pt;">Notwithstanding the mitigating factors identified by management, there remains substantial doubt regarding the Company's ability to meet its obligations as they arise over the next <em style="font: inherit;">twelve</em> months. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 25pt;"> </p>
CY2023Q2	mind	Working Capital Deficit WorkingCapitalDeficit	13700000	usd
CY2023Q2	us-gaap	Cash Cash	815000	usd
CY2023Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	22600000	usd
CY2023Q2	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1178000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	571000	usd
CY2023Q2	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">2.</em> Basis of Presentation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">The condensed consolidated balance sheet as of <em style="font: inherit;"> January 31, 2023</em>, for the Company has been derived from audited consolidated financial statements. The unaudited interim condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented <em style="font: inherit;">not</em> misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the related notes included in the Company’s Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> January 31, 2023</em> (“fiscal <em style="font: inherit;">2023”</em>). In the opinion of the Company’s management, all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position as of <em style="font: inherit;"> April 30, 2023</em>, the results of operations for the <em style="font: inherit;">three</em>-months ended <em style="font: inherit;"> April 30, 2023 </em>and <em style="font: inherit;">2022</em>, the cash flows for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> April 30, 2023 </em>and <em style="font: inherit;">2022</em>, and the statement of stockholders’ equity for the <em style="font: inherit;">three</em>-months ended <em style="font: inherit;"> April 30, 2023 </em>and <em style="font: inherit;">2022</em>, have been included in these condensed consolidated financial statements. The foregoing interim results are <em style="font: inherit;">not</em> necessarily indicative of the results of operations to be expected for the full fiscal year ending <em style="font: inherit;"> January </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2024</em> (“fiscal <em style="font: inherit;">2024”</em>).</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 25pt;"> </p>
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12586000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9087000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12586000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9087000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	13000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	13000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2000	usd
CY2023Q2	mind	Contract With Customer Liability And Customer Deposits Current ContractWithCustomerLiabilityAndCustomerDepositsCurrent	1178000	usd
CY2023Q1	mind	Contract With Customer Liability And Customer Deposits Current ContractWithCustomerLiabilityAndCustomerDepositsCurrent	571000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	8341000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	8480000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3657000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4156000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	4079000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	4422000	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	16077000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	17058000	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1738000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1740000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	14339000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	15318000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15146000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15134000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11359000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11189000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3787000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3945000	usd
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	221000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	203000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1762000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1749000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1762000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1749000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	753000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	903000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1009000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	846000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1762000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1749000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y11M23D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.13	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.13	pure
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	221000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	203000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	223000	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	753000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	691000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	294000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	188000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	188000	usd
CY2023Q2	mind	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	15000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2129000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	367000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1762000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	18840000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-13416000	usd
CY2023Q2	mind	Finitelived Intangible Assets Impaired Accumulated Impairment Loss FinitelivedIntangibleAssetsImpairedAccumulatedImpairmentLoss	760000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4664000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	18831000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-13140000	usd
CY2023Q1	mind	Finitelived Intangible Assets Impaired Accumulated Impairment Loss FinitelivedIntangibleAssetsImpairedAccumulatedImpairmentLoss	760000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4931000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	276000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	271000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	418000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	178000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	211000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2600000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13800000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2594000	usd
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1683000
CY2023Q2	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	43900000	usd
CY2023Q2	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	3800000	usd
CY2023Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25.00
CY2023Q2	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	3800000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	236000	usd
CY2023Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2023Q2	us-gaap	Assets Assets	33845000	usd
CY2023Q1	us-gaap	Assets Assets	32858000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12586000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9087000	usd
CY2023Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	7169000	usd
CY2022Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	5798000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	481000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	479000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	-204000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	-4000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	289000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2476000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	289000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2476000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	-204000	usd
	us-gaap	Interest Expense InterestExpense	-4000	usd
CY2023Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-93000	usd
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	114000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	178000	usd

Files In Submission

Name	View Source	Status
mind-20230430_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mind-20230430_pre.xml	Edgar Link	unprocessable
0001437749-23-017412-index-headers.html	Edgar Link	pending
0001437749-23-017412-index.html	Edgar Link	pending
0001437749-23-017412.txt	Edgar Link	pending
0001437749-23-017412-xbrl.zip	Edgar Link	pending
ex_499921.htm	Edgar Link	pending
ex_499922.htm	Edgar Link	pending
ex_499923.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mind-20230430.xsd	Edgar Link	pending
mind20230411_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
mind20230411_10q_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mind-20230430_lab.xml	Edgar Link	unprocessable
mind-20230430_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MIND
MIND TECHNOLOGY, INC Stock $mind

2023 Q2 Form 10-Q Financial Statement

#000143774923017412 Filed on June 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MIND MIND TECHNOLOGY, INC Stock $mind

2023 Q2 Form 10-Q Financial Statement

#000143774923017412 Filed on June 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MIND
MIND TECHNOLOGY, INC Stock $mind